Evidence of Epstein-Barr virus infection in ulcerative colitis

Digestive and Liver Disease

Volumn 33, Issue 7, 2001, Pages 551-558

  Bertalot, G ^a   Villanacci, V ^b   Gramegna, M ^c   Orvieto, E ^d   Negrini, R ^e   Saleri, A ^f   Terraroli, C ^g   Ravelli, P ^h   Cestari, R ^g   Viale, G ⁱ  

^a Ospedale di Leno   (Italy)

^b Spedali Di Civili   (Italy)

^c Clonit SpA   (Italy)

^d Treviso Hospital   (Italy)

^e SPEDALI CIVILI   (Italy)

^f Department of Gastroenterology and Digestive Endoscopy   (Italy)

^g UNIVERSITY OF BRESCIA   (Italy)

^h Azienda Dspedaliera “Bolognini” ^*  (Italy)

ⁱ UNIVERSITY OF MILAN   (Italy)

Author keywords

CD4+T cells; EBER1 2; Epstein Barr virus; Ulcerative colitis

Indexed keywords

EBER 1 PROTEIN; EBER 2 PROTEIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN; VIRUS RNA;

ADULT; AGED; ARTICLE; CHRONICITY; CLINICAL ARTICLE; CLINICAL STUDY; COLITIS; COLON CROHN DISEASE; COLON RESECTION; CONTROLLED STUDY; DNA STRUCTURE; EPITHELIUM CELL; EPSTEIN BARR VIRUS; ETIOLOGY; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; INTESTINE BIOPSY; INTESTINE MUCOSA; LARGE INTESTINE MUCOSA; LYSIS; NONHUMAN; PERIPHERAL LYMPHOCYTE; POLYMERASE CHAIN REACTION; SMALL INTESTINE MUCOSA; TISSUE INJURY; ULCERATIVE COLITIS; VIRUS EXPRESSION; VIRUS INFECTION;

ADULT; AGED; ANTIBODIES, VIRAL; BIOPSY; COLITIS, ULCERATIVE; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; NUCLEIC ACID AMPLIFICATION TECHNIQUES; POLYMERASE CHAIN REACTION;

EID: 0034778092     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(01)80106-7     Document Type: Article

References (39)

1. Cytoplasmic antineutrophil cytoplasmic antibody-positive vasculitis associated with ulcerative colitis
2. Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives
3. Modern life in the epidemiology of inflammatory bowel disease: A case-control study with special emphasis on nutritional factors
4. Elevated serum levels and reduced immunohistochemical expression of thrombomodulin in active ulcerative colitis
5. Nachweis von EBV- und HSV (I+II)-DNS in der Ileum- und Kolonschleimhaut bei kolorektalen Karzinomen, morbus Crohn und colitis ulcerosa
6. Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn’s disease using the nested polymerase chain reaction
7. Measles IgM immunoreactivity in patients with inflammatory bowel disease
8. Cancer and inflammatory bowel disease: Bias, epidemiology, surveillance, and treatment
9. Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease
10. Epstein-Barr virus infection of the colon with inflammatory bowel disease
11. Epstein-Barr Virus and Kaposi’s Sarcoma Herpesvirus/Human Herpesvirus 8
12. Epstein-Barr virus
13. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation CD 23
14. Induction of bcl2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death
15. Abundant expression of EBER 1 small nuclear RNA in nasopharyngeal carcinoma: A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens
16. Molecular diagnosis of Epstein-Barr virus-related diseases
17. Human B cell interleukin 10
18. Properties and functions of interleukin-10
19. Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells
20. Interleukin-5 is an autocrine growth factor for Epstein-Barr virus transformed B lymphocytes
21. An interleukin 12-related cytokine is upregulated in ulcerative colitis but not in Crohn’s disease
22. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest secretion of IL-5
23. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
24. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
25. Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes
26. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjögren’s syndrome
27. Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas
28. The structure of the termini of the Epstein Barr virus as a marker of clonal cellular proliferation
29. A novel form of Epstein-Barr latency in normal B cells in vivo
30. Association of Epstein-Barr virus with leiomyosarcomas in young people with AIDS
31. Activated CD4+ and CD8+ cytotoxic cells are present in increased numbers in the intestinal mucosa from patients with inflammatory bowel disease
32. Functional analysis of the CD4+ T-cell response to Epstein-Barr virus: T-cell-mediated activation of resting B cells and induction of viral BZLF1 expression
33. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRF1
34. Immunological disorders in inflammatory bowel disease and immunotherapeutic implications
35. Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease
36. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease
37. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4
38. Interleukin-10 expression and cytotoxic-T-cell response in Epstein-Barr-virus-associated nasopharyngeal carcinoma